The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo

Cardiovascular Research
P HolmA Franco-Cereceda

Abstract

Elevated levels of the potent vasoactive peptide endothelin (ET), have been found in pathophysiological conditions associated with pulmonary hypertension. In this study, we have investigated the effects of the ETA receptor antagonist, BMS-182874, on hypoxic pulmonary hypertension in pigs. Pigs were subjected to acute, intermittent 15-min periods of hypoxia (FiO2 0.1). Following a first hypoxia establishing hypoxic baseline values, vehicle or BMS-182874 (10 or 30 mg/kg) was administered i.v. before a second hypoxic period. In separate groups of animals, the effects of the nitric oxide synthase inhibitor N omega-nitro-L-arginine (L-NNA) in combination with BMS-182874 (10 mg) during repeated hypoxia were investigated. The ET-1-blocking properties of BMS-182874 were studied in vivo by infusion of ET-1 during normoxia and in vitro using isolated porcine pulmonary arteries. The hypoxia-evoked increase in mean pulmonary artery pressure was reduced by administration of BMS-182874 (10 mg/kg i.v.; from 42 +/- 8 to 34 +/- 4 mmHg, P < 0.05 and 30 mg/kg i.v.; from 38 +/- 4 to 30 +/- 5 mmHg, P < 0.05). In addition, BMS-182874 at 30 mg/kg reduced the pulmonary vascular resistance during hypoxia (from 7.4 +/- 1.5 to 5.3 +/- 1.1 mmHg.min.l-1 P ...Continue Reading

Citations

Jul 20, 2002·Respiratory Physiology & Neurobiology·Philip I AaronsonJeremy P T Ward
Oct 7, 2000·Clinical and Experimental Pharmacology & Physiology·S Kim-Park, D D Ku
Jun 29, 2000·American Journal of Respiratory Cell and Molecular Biology·B HocherF Theuring
Dec 1, 2001·Biological & Pharmaceutical Bulletin·K Goto
Jul 1, 2008·Pharmacology & Therapeutics·Daphne MerkusDirk J Duncker
Oct 13, 2005·Pharmacology & Therapeutics·Sophie MotteRobert Naeije
Mar 10, 2004·The Journal of Pharmacy and Pharmacology·Aarati RaiAnil Gulati
Nov 20, 2002·Pediatric Research·Namasivayam AmbalavananYiu-Fai Chen
Feb 3, 2012·Physiological Reviews·J T SylvesterJeremy P T Ward
Dec 14, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bodil PetersenThilo Busch
Aug 5, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·J S ShamJ T Sylvester
Jul 4, 2003·Canadian Journal of Physiology and Pharmacology·Bruno Battistini
Jan 21, 2000·Journal of Applied Physiology·S DoiP A Murray
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Wendy JohnsonMark A Creager
Jul 27, 2001·Equine Veterinary Journal·A E BenamouP Lekeux
Apr 6, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·Q LiuJ T Sylvester

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.